We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 8,772 results
  1. Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata

    Background

    Axitinib is an oral vascular endothelial growth factor receptor inhibitor with anti-tumour activity in renal, thyroid, and pancreatic...

    Penella J. Woll, Piers Gaunt, ... Lucinda Billingham in British Journal of Cancer
    Article Open access 08 September 2023
  2. X-linked recessive ichthyosis in 8 Tunisian patients: awareness of misdiagnosis due to the technical trap of the STS pseudogene

    Introduction

    X-linked recessive ichthyosis (XLI) is a genodermatosis, caused by a deficiency of the steroid sulphatase enzyme encoded by the STS gene...

    Hamza Chouk, Sarra Saad, ... Dorra H’mida in BMC Medical Genomics
    Article Open access 26 July 2022
  3. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)

    Background

    Metastatic soft tissue sarcoma (STS) are a heterogeneous group of malignancies which are not curable with chemotherapy alone. Therefore,...

    Vasileia Tsintari, Bianca Walter, ... Kerstin M. Kampa-Schittenhelm in BMC Cancer
    Article Open access 02 July 2022
  4. Evaluation of the accuracy of algorithms to identify soft tissue sarcoma (STS) in administrative claims

    Background

    Lack of using a validated algorithm to select patients is a source of selection bias in oncology studies using administrative claims. The...

    Nicole Princic, Donna McMorrow, ... Lisa Hess in Clinical Sarcoma Research
    Article Open access 05 May 2020
  5. Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study

    Metabolic elevation in soft-tissue sarcomas (STS), as documented with 18 F-Fluorodeoxyglucose positron emission tomography ( 18 F-FDG-PET/CT) has been...

    Amandine Crombé, Frédéric Bertolo, ... Antoine Italiano in Biomarker Research
    Article Open access 07 January 2024
  6. The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma– does it influence prognosis?

    Background

    Soft tissue sarcomas (STSs) are a heterogeneous group of tumors. Wide surgical resection is standard, often combined with neoadjuvant...

    Julian Fromm, Alexander Klein, ... Hans Roland Dürr in BMC Cancer
    Article Open access 06 March 2024
  7. Sodium Tanshinone IIA Sulfonate Ameliorates Oxygen-glucose Deprivation/Reoxygenation-induced Neuronal Injury via Protection of Mitochondria and Promotion of Autophagy

    Sodium tanshinone IIA sulfonate (STS) has shown significant clinical therapeutic effects in cerebral ischemic stroke (CIS), but the molecular...

    Zhi Ma, Yue Wu, ... Feng Qiu in Neurochemical Research
    Article 12 July 2023
  8. Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms

    We aimed to develop and validate a predictive model for identifying long-term survivors (LTS) among glioblastoma (GB) patients, defined as those with...

    **-Lin Yang, Zheng Zeng, ... **n Lian in Journal of Molecular Neuroscience
    Article 25 April 2024
  9. The 1-min sit-to-stand test induces a significant and reliable level of neuromuscular fatigability: insights from a mobile app analysis

    Purpose

    The performance metric associated with the execution of the 1-min sit-to-stand (1STS) typically relies on the number repetitions completed in...

    Robin Souron, Juan D. Ruiz-Cárdenas, Mathieu Gruet in European Journal of Applied Physiology
    Article 20 June 2024
  10. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial

    Background

    The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a...

    Thomas Filleron, Sophie Le Guellec, ... Thibaud Valentin in BMC Cancer
    Article Open access 31 July 2020
  11. PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcoma

    Background

    We aimed to examine whether PTEN pathogenic variants (mutPTEN) were associated with overall survival (OS) in patients with advanced soft...

    Minggui Pan, Maggie Y. Zhou, ... Laurel A. Habel in BJC Reports
    Article Open access 30 January 2024
  12. Amputation in patients with extremity soft tissue sarcoma: the experience of an East Asian referral center

    Background

    This study aimed to investigate the characteristics and clinical outcomes in a series of patients with extremity soft tissue sarcoma (STS)...

    Yongsung Kim, Han-Soo Kim, Ilkyu Han in BMC Cancer
    Article Open access 11 January 2024
  13. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma

    Background

    Soft tissue sarcomas (STS), have significant inter- and intra-tumoral heterogeneity, with poor response to standard neoadjuvant...

    Arash O. Naghavi, J. M. Bryant, ... James Costello in BMC Cancer
    Article Open access 09 April 2024
  14. First Molecular Identification and Subty** of Blastocystis sp. in the Most Consumed Edible Marine Fish of Iran: A Foodborne Concern

    Purpose

    The presence of Blastocystis sp. is commonly observed in humans and different animals, displaying a wide range of genetic variations with the...

    Ali Asghari, Shaghayegh Banavand, ... Gholamreza Hatam in Acta Parasitologica
    Article 06 January 2024
  15. Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models

    Background

    Despite their heterogeneity, the current standard preoperative radiotherapy regimen for localized high-grade soft tissue sarcoma (STS)...

    Siyer Roohani, Jürgen Loskutov, ... David Kaul in BMC Cancer
    Article Open access 22 June 2023
  16. Evaluation of prophylactic efficacy of sodium thiosulfate in combating I/R injury in rat brain: exploring its efficiency further in vascular calcified brain slice model

    Cerebral ischemia reperfusion injury (CIR) is one of the clinical manifestations encountered during the management of stroke. High prevalence of...

    Keerthana Baskaran, Jefri Thimoathi Johnson, ... Gino A Kurian in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 14 April 2023
  17. Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma

    Lymph node metastasis (LNM) occurs in less than 5% of soft tissue sarcoma (STS) patients and indicates an aggressive course of disease. Suspicious...

    Anton Burkhard-Meier, Vindi Jurinovic, ... Lars H. Lindner in Clinical & Experimental Metastasis
    Article Open access 29 February 2024
  18. Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib

    Background

    Soft tissue sarcomas (STS) are a rare type of malignancy comprising a variety of histological diagnoses. Chemotherapy constitutes the...

    Makoto Endo, Tomoko Kataoka, ... Kazuhiro Tanaka in BMC Cancer
    Article Open access 08 March 2023
  19. Resha** the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

    Most soft-tissue sarcomas (STS) exhibit an immunosuppressive tumor microenvironment (TME), leading to resistance against immune checkpoint inhibitors...

    Maud Toulmonde, Jean-Philippe Guegan, ... Antoine Italiano in Molecular Cancer
    Article Open access 20 February 2024
Did you find what you were looking for? Share feedback.